SILENCE THERAPEUTICS PLC-ADR (SLN) Stock Income Statement
USA - NASDAQ:SLN - US82686Q1013 - ADR
6.61 USD
-0.55 (-7.68%)
6.5 USD
-0.11 (-1.66%)
| TTM (2025-6-30) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 45.10M | 5.48M | 244.00K | 0.00 | 16.00K | |||
| Cost Of Goods | 15.56M | 3.76M | N/A | N/A | N/A | |||
| Gross Profit | 29.56M | 1.72M | N/A | N/A | N/A | |||
| Operating Expenses | 173.43M | 37.56M | 22.98M | 20.57M | 14.41M | |||
| Research and Development | 126.15M | 20.21M | 13.34M | 9.74M | 7.94M | |||
| Selling, General, and Administrative Expenses | 46.98M | 13.98M | 9.64M | 10.83M | 6.46M | |||
| Operating Income | -143.37M | -35.85M | -22.73M | -20.57M | -14.39M | |||
| Interest Income/Expense | -18.90M | -194.00K | -136.00K | 45.00K | 10.66M | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | -49.00K | |||
| Income Before Taxes | -139.34M | -36.04M | -22.87M | -20.53M | -3.77M | |||
| Income Tax | -3.23M | -3.49M | -3.29M | -2.12M | -2.16M | |||
| Net Income | -136.19M | -32.55M | -19.58M | -18.41M | -1.62M | |||
| EBITDA | N/A | -35.35M | -22.25M | -20.17M | -13.96M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.91 | -0.40 | -0.26 | -0.26 | -0.02 | |||
| Non GAAP EPS | N/A | -0.40 | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 65.55% | 31.34% | N/A | N/A | N/A | |||
| Profit Margin | -301.97% | -594.03% | -8025.41% | N/A | -10112.50% | |||
| Operating Profit Margin | -317.87% | -654.26% | -9317.21% | N/A | -89943.75% | |||
All data in USD